key: cord-0982281-vqjwlpsl authors: Li, Zhenjun; Jiang, Jiafu; Tong, Yigang; Ruan, Xiangdong; Xu, Jianguo title: COVID-19 is a natural infectious disease date: 2021-12-11 journal: J Biosaf Biosecur DOI: 10.1016/j.jobb.2021.11.001 sha: 3b8b23007dd724296c2ca1b4b93fbe92283ea647 doc_id: 982281 cord_uid: vqjwlpsl COVID-19 is an infectious disease that has emerged naturally, not accidentally or deliberately. Similarly, SARS-CoV-2 is not a man-made or genetically modified virus. Reverse genetic technology can only be used to produce infectious clones of a known virus. Phylogenetically, the RaTG13 genome sequence recovered from bats is the most closely related viral sequence to SARS-CoV-2; however, the corresponding RaTG13 virus is yet to be isolated or cultured in a laboratory. Therefore, the so-called bat coronavirus RaTG13 could not have been used as a starting strain or “backbone” for genetic modification. Furthermore, it would be impossible to generate SARS-CoV-2 by inserting the furin cleavage site into the bat coronavirus RaTG13. It is critical for the prevention and control of SARS-CoV-2 to investigate the animal reservoirs of SARS-CoV-2, and this work is ongoing. From the prospective of biosafety and biosecurity, outbreaks of infectious diseases can be classified into three types: natural, accidental, and deliberate (1,2). There is a large body of evidence that COVID-19 is caused by a natural virus. It has no characteristics of an accidental or deliberate infection (3). identical to that isolated from the patients 2 . In 2001, a microbiologist in the US army coordinated a large-scale biological threat by contaminating mail with anthrax. The strain of anthrax identified from the mail was identical to that stored in the military research laboratory 18,20 . Therefore, the most important evidence for identifying an infection outbreak as the result of the deliberate spread of an existing deadly virus is the genome level identity between the strain isolated from the patient and the strain from the suspected laboratory. Technically, it is easy to determine whether two strains are genetically identical 2 . Some laboratories have the capacity to synthesize large gene fragments that exceed the length of known viral genomes. However, this does not necessarily mean that such laboratories have the capability to design and create a novel virus or bacterium. Current biological technology would make it possible for researchers to generate a pathogen based on naturally-occurring sequences, potentially even with some modifications. However, to date, no novel species of virus or bacterium has been created with a human-designed sequence that differs significantly from known natural sequences. No pathogen recognized by the World Health Organization (WHO), the International Committee on Taxonomy of Viruses (ICTV), or the International Committee on Systematics of Prokaryotes (ICSP) has been wholly designed and generated by humans. This is currently beyond scientific capabilities. Some laboratories can use reverse genetic techniques to generate SARS-CoV-2 infectious clones, based on the genome sequence of the known virus 21-23 . There may be some misunderstanding among non-experts regarding virus taxonomy and the difference between new viruses and infectious clones, and modified viruses generated by reverse genetic techniques or synthetic biology 24 . Viruses are obligate intracellular parasites that probably infect all cellular forms of life 25 . Advances in metagenomic sequencing technologies have revealed the wide range of viromes that are ubiquitous in the biosphere. It has been estimated that at least 10 31 virus particles exist globally at any given time 25 . Taxonomy based on metagenomic sequence data alone represents a substantial departure from the traditional reliance on phenotypic properties. The viruses that have been revealed by detection of their genome sequence from metagenomic analysis are not fully recognized as real (cultured) viruses by many virologists. Viruses can be divided into two types: a real virus that has been cultured, and a putative virus that has not been cultured and for which only the genome sequence is available. SARS-CoV-2 isolated from patients is a real virus that has been cultured. By contrast, bat coronavirus RaTG13 has not yet been cultured and its taxonomy is based on its sequence alone. Therefore, RaTG13 is not considered a real live virus 26 . Traditional culturing methods, including repeated sub-culturing on a specific medium, have been used to attenuate pathogen virulence without changing immunogenicity. The application of such methods in vaccine development can be dated back over a century, when these methods were successfully used for the development of a live attenuated vaccine against Shigella and many other pathogens. Insertion, deletion, and editing of gene sequences are routine procedures for the modification of bacteria or viruses in basic microbiological studies, such as those investigating pathogenic mechanisms. Some researchers have used gene manipulation to enhance the virulence or infectivity of particular pathogenic microorganisms, such as influenza virus. The highly pathogenic avian influenza (HPAI) H5N1 virus occasionally infects humans, but it does not transmit efficiently from person to person 27 . A group of Japanese and American scientists and a clear understanding of which gene is to be modified, as well as its expected function. There was no starting strain or "backbone" available to generate SARS-CoV-2 3 . The bat coronavirus RaTG13 was suggested as the starting strain, but RaTG13 exists only as a genome sequence recovered from a bat. Even the technique proposed in a recent report for the creation of SARS-CoV-2 by insertion of the furin cleavage site into the bat coronavirus RaTG13 is untenable 34 . If this was the case, when the inserted furin cleavage site is removed from SARS-CoV-2, the remaining genome sequence of SARS-CoV-2 should be identical to that of bat coronavirus RaTG13 35, 36 . However, although RaTG13 shares 96% similarity with SARS-CoV-2, these sequences still differ by 1,177 nucleic acids. Therefore, the use of the furin cleavage site to create SARS-CoV-2 from RaTG13 is a falsified claim 34 . When a mutant SARS-CoV-2 that lacks the furin cleavage site (Delta PRRA) was generated, the mutant showed reduced replication in a human respiratory cell line and was attenuated in both hamsters and K18-hACE2 transgenic mice 30 . SARS-CoV-2 efficiently utilized the ACE2 receptor of nine animal species to infect 293T cells. It thereby appears that the furin site is important for the pathogenicity of SARS-CoV-2. This was not the case for the bat coronavirus RaTG13 sequence. The pseudoviruses bearing S protein derived from either bat RaTG13 or pangolin GX utilized the ACE2 receptors of a diverse range of animal species to gain entry. The insertion of PRRA into the RaTG13 S protein Infectious diseases. Second lab accident fuels fears about SARS Accidental Russian spring-summer viral encephalitis cases occurring in two laboratory workers, one fatal, with postmortem study Accidental contamination of a specified-pathogen-free unit The accidental infection of a laboratory worker with Toxoplasma gondii Import of animal viruses opposed after accident at laboratory Inaugural editorial: Towards evidence-based biosafety and biosecurity Accidental infection of laboratory worker with recombinant vaccinia virus Singapore lab faulted in SARS case Infectious diseases. Early indications point to lab infection in new SARS case The Sverdlovsk anthrax outbreak of 1979 SARS-CoV-2 Spike Glycoprotein: A Computational Study Linking Viral Evolution and Infection Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets Natural selection in the evolution of SARS-CoV-2 in bats, not humans, created a highly capable human pathogen A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein Molecular Biology Clues Portray SARS-CoV-2 as a Gain-of-Function Laboratory Manipulation of Bat CoV RaTG13 Comparative Genomic Analyses Reveal a Specific Mutation Pattern Between Human Coronavirus SARS-CoV-2 and Bat-CoV RaTG13 Analysis of the Genomic Distance Between Bat Coronavirus RaTG13 and SARS-CoV-2 Reveals Multiple Origins of COVID-19 The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat RaTG13 Hemorrhagic colitis associated with a rare Escherichia coli serotype The coronavirus is rife in common US deer SARS-CoV infection in a restaurant from palm civet Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms Molecular Evidence for SARS-CoV-2 in Samples Collected From Patients With Morbilliform Eruptions Since Late Summer 2019 in Lombardy